Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway

References

• HurvitzSMeadMTriple-negative breast cancer: advancements in characterization and treatment approachCurr Opin Obstet Gynecol2016281596926694831
   PubMed Web of Science ®Google Scholar
• KumarPAggarwalRAn overview of triple-negative breast cancerArch Gynecol Obstet2016293224726926341644
   PubMed Web of Science ®Google Scholar
• YaoHHeGYanSTriple-negative breast cancer: is there a treatment on the horizon?Oncotarget2017811913192427765921
   PubMedGoogle Scholar
• El RassyEIbrahimNGhosnMTriple negative breast cancer: are we scoring a home run?Future Oncol201814979379629527949
   PubMed Web of Science ®Google Scholar
• BradySNMaggiLBWinkelerCLNucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferationOncogene200928363209322019561638
   PubMed Web of Science ®Google Scholar
• BoxJKPaquetNAdamsMNNucleophosmin: from structure and function to disease developmentBMC Mol Biol20161711927553022
   PubMedGoogle Scholar
• HuLZhangXWangJWangSAminHMShiPInvolvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK+ anaplastic large cell lymphomaHematology201823528429029086626
   PubMed Web of Science ®Google Scholar
• LinJKatoMNagataKOkuwakiMEfficient DNA binding of NF-κB requires the chaperone-like function of NPM1Nucleic Acids Res20174573707372328003476
   PubMed Web of Science ®Google Scholar
• di MatteoAFranceschiniMChiarellaSRocchioSTravaglini-AllocatelliCFedericiLMolecules that target nucleophosmin for cancer treatment: an updateOncotarget2016728448214484027058426
   PubMedGoogle Scholar
• ZhouFQiuWSunLClinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancersAPMIS2013121758259123489260
   PubMed Web of Science ®Google Scholar
• LiuYZhangFZhangXFExpression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cellsJ Biomed Sci2012195322631075
   PubMed Web of Science ®Google Scholar
• XuDHLiuFLiXRegulatory role of nucleophosmin during the differentiation of human liver cancer cellsInt J Oncol201445126427224787960
   PubMed Web of Science ®Google Scholar
• KimJYChoYEAnYMGLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancerJ Cell Mol Med20151961245125225818168
   PubMed Web of Science ®Google Scholar
• Di FiorePPPlaying both sides: nucleophosmin between tumor suppression and oncogenesisJ Cell Biol200818217918625839
   PubMed Web of Science ®Google Scholar
• ZhouFChenEYouDSongYSunZYueLBoth high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancerAPMIS2016124121046105327714846
   PubMed Web of Science ®Google Scholar
• LealMFMazzottiTKCalcagnoDQDeregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implicationsBMC Gastroenterol201414924410879
   PubMed Web of Science ®Google Scholar
• KarhemoPRRivinojaALundinJAn extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancerAm J Pathol201117921004101421689627
   PubMed Web of Science ®Google Scholar
• LinHYZengDLiangYKWeiXLChenCFGATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignanciesOncotarget2017821347503476128423734
   PubMedGoogle Scholar
• LánczkyANagyÁBottaiGmiRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patientsBreast Cancer Res Treat2016160343944627744485
   PubMed Web of Science ®Google Scholar
• ParejaFReis-FilhoJSTriple-negative breast cancers - a panoply of cancer typesNat Rev Clin Oncol201815634734829555966
   PubMed Web of Science ®Google Scholar
• LeeADjamgozMBATriple negative breast cancer: emerging therapeutic modalities and novel combination therapiesCancer Treat Rev20186211012229202431
   PubMed Web of Science ®Google Scholar
• LebertJMLesterRPowellESealMMcCarthyJAdvances in the systemic treatment of triple-negative breast cancerCurr Oncol201825Suppl 1S142S15029910657
   PubMed Web of Science ®Google Scholar
• Chalakur-RamireddyNKRPakalaSBCombined drug therapeutic strategies for the effective treatment of Triple Negative Breast CancerBiosci Rep2018381BSR2017135729298879
   PubMedGoogle Scholar
• ScottDDOeffingerMNucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repairBiochem Cell Biol201694541943227673355
   PubMedGoogle Scholar
• LinCYChaoAWangTHNucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cellsOncotarget2016737600386005227527851
   PubMedGoogle Scholar
• AhnJYLiuXChengDNucleophosmin/B23, a nuclear PI(3,4,5) P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CADMol Cell200518443544515893727
   PubMed Web of Science ®Google Scholar
• BolliNde MarcoMFMartelliMPA dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARFLeukemia200923350150919005479
   PubMed Web of Science ®Google Scholar
• ChanHJWengJJYungBYNucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53Biochem Biophys Res Commun2005333239640315950182
   PubMed Web of Science ®Google Scholar
• HeJXiangZXiaoJXiaoHLiuLThe poor chemotherapeutic efficacy in lung adenocarcinoma overexpressing c-Src and nucleophosmin/B23(NPM1)Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi201632101378138127667466
   PubMedGoogle Scholar
• LiuYPerdreauSAChatterjeePWangLKuanSFDuensingAImatinib mesylate induces quiescence in gastrointestinal stromal tumor cells through the CDH1-SKP2-p27Kip1 signaling axisCancer Res200868219015902318974147
   PubMed Web of Science ®Google Scholar
• ChenCFDouXWLiangYKNotch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cellsCell Cycle201615343244026694515
   PubMed Web of Science ®Google Scholar
• BellettiBBaldassarreGNew light on p27(kip1) in breast cancerCell Cycle201211193701370222895010
   PubMed Web of Science ®Google Scholar
• ChenSMengTZhengXContribution of nucleophosmin over-expression to multidrug resistance in breast carcinomaJ Drug Target2018261273528562134
   PubMed Web of Science ®Google Scholar
• YangYFZhangXYYangMPrognostic role of nucleophosmin in colorectal carcinomasAsian Pac J Cancer Prev20141552021202624716928
   PubMedGoogle Scholar
• KuoYHChenYTTsaiHPChaiCYKwanALNucleophosmin overexpression is associated with poor survival in astrocytomaAPMIS2015123651552225907517
   PubMed Web of Science ®Google Scholar